People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CTRL Therapeutics USA, Inc. | — | Biotechnology | Series A | $16.6M | $43.1M | 2022 |
| IMV Inc. | — | Biotechnology | Seed | $4.3M | $14.8M | 2021 |
Michael Kalos at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Kalos on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Bailey | 1 | 6 |
| DAVID O'NEILL | 1 | 4 |
| Andrew Hall | 1 | 4 |
| Elena Viboch | 1 | 4 |
| Julia P. Gregory | 1 | 3 |
| Markus Warmuth | 1 | 3 |
| Julia Gregory | 1 | 3 |
| Kyle Kuvalanka | 1 | 3 |
| Shermaine Tilley | 1 | 3 |
| Pierre Labbe | 1 | 2 |
| Shana Kelley | 1 | 1 |
| Collin Todd | 1 | 1 |
| Jeremy Graff | 1 | 1 |
| Andrew Sheldon | 1 | 1 |
| Derrell Porter | 1 | 1 |
| James P. Hall | 1 | 1 |
| Wayne P. Pisano | 1 | 1 |
| Markus P. Warmuth | 1 | 1 |
| Frederic Ors | 1 | 1 |
| Shermaine P. Tilley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.